2025 IMS Myeloma: Understanding the Landscape
Multiple myeloma (MM) is a cancer of the plasma cells, a type of white blood cell that produces antibodies. It is the second most common blood cancer, after non-Hodgkin lymphoma. MM is a complex and challenging disease to treat, but there have been significant advances in recent years. The International Myeloma Society (IMS) 2025 initiative … Read more
